ArticleJournal of inflammation research2021

In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer.

Bashir Lawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.